News Wire

Manufacturers Would Still Make a Good Profit If Costs Are Cut, Study Says
The experiments that produce “miracle” drugs do not often reflect a diverse population.
Conversely, Kids Who Need Drugs Go Untreated
May Reduce the Need for Open-Heart Surgery
NDEA, a Known Carcinogen, Discovered During FDA Testing
Cleared for Adults with Relapsed or Refractory Disease
Speed of approval surprises some experts, though states still have to sign off on Cigna’s $67 billion purchase of the pharmacy benefits manager.
August peer-reviewed publication ignores demands that article be retracted.
Some physicians and advocacy groups argue that trying the cheaper drug first might lead to worse outcomes.
Signs suggest that the companies are finally coming out of a long-running market “nightmare.”
Approved as Maintenance Treatment for Opioid Dependence
Says Company’s OxyContin Had “Significant Role” in Opioid Epidemic
Study Uses Experimental Software to Decode Variations in Mood
Calls new generic drug company formed by hospital consortium a response to “untenable” circumstances.